Business1 min read

Judge approves $7.25bn Bayer payout to settle claims that Roundup causes cancer

By · Via The Guardian Business · Published by Everything Blog

In short

The court ruled that the deal was fair and adequate, dismissing objections that individual payouts were smaller than past awards. The decision arrives after a 7-2 Supreme Court ruling curbed state-level failure-to-warn claims, severely limiting alternative legal options for individuals alleging glyphosate exposure caused their illness. Although the accord aims to resolve the vast majority of current and future domestic exposure cases, Bayer continues to litigate about 200 federal lawsuits.

Key points

  • A recent Supreme Court decision barred state-level failure-to-warn claims, drastically na…: A recent Supreme Court decision barred state-level failure-to-warn claims, drastically narrowing available legal paths for weedkiller cancer victims.
  • The comprehensive nationwide deal is designed to resolve nearly all current and prospecti…: The comprehensive nationwide deal is designed to resolve nearly all current and prospective domestic cancer claims against Bayer.
  • Bayer maintains that scientific studies prove glyphosate does not cause cancer despite fi…: Bayer maintains that scientific studies prove glyphosate does not cause cancer despite financing this multi-billion dollar resolution.

Sources checked by our analysis pipeline: 1

A Missouri judge on Friday approved Bayer’s $7.25bn settlement of lawsuits alleging that its weedkiller Roundup causes cancer, potentially resolving litigation that has weighed on the German company for close to a decade.

Judge Timothy Boyer of a state court in St Louis found the settlement “fair, reasonable and adequate”.

He overruled objections that payouts to individual cancer victims would be too low because claimants who previously settled were paid more.

The judge also said delaying payouts could force victims, including those whose cancer is terminal, to wait “an indeterminate number of years” to be paid.

Bayer had faced approximately 65,000 claims in US state and federal courts from people who said they developed cancer after using Roundup at home or on the job.

The settlement announced in February aimed to resolve nearly all current and future Roundup claims in the US.

“The court’s final approval is a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” Bayer’s CEO, Bill Anderson, said in a statement.

Bayer has faced extensive litigation over Roundup,…

Business